Non‐Vitamin K Antagonist Oral Anticoagulants Provide Less Adverse Renal Outcomes Than Warfarin In Non‐Valvular Atrial Fibrillation: A Systematic Review and MetaAnalysis

BACKGROUND: Non‐vitamin K antagonist oral anticoagulants (NOACs) have better pharmacologic properties than warfarin and are recommended in preference to warfarin in most patients with non‐valvular atrial fibrillation. Besides lower bleeding complications, other advantages of NOACs over warfarin part...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Am Heart Assoc
Egile Nagusiak: Sitticharoenchai, Patita, Takkavatakarn, Kullaya, Boonyaratavej, Smonporn, Praditpornsilpa, Kearkiat, Eiam‐Ong, Somchai, Susantitaphong, Paweena
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2021
Gaiak:
Systematic Review and Meta‐analysis
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8174352/
https://ncbi.nlm.nih.gov/pubmed/33728927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.120.019609
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak